PedAM
Pediatric Disease Annotations & Medicines
| Disease | interstitial lung disease |
| Phenotype | C0011644|scleroderma |
| Sentences | 8 |
| PubMedID- 21314931 | 46 scleroderma patients with evidence of interstitial lung disease on high resolution computed tomography (hrct) (reticular pattern and/or ground glass or honeycombing), consecutively admitted to the outpatient clinic of the rheumatology division of the catholic university in rome from january 2007 to december 2009, consenting to undergo bronchoalveolar lavage, have been included in the study. |
| PubMedID- 24448503 | Objective: this study aimed to determine the relationship between main pulmonary artery diameter (mpad) and pulmonary hypertension (ph) in scleroderma patients with and without interstitial lung disease. |
| PubMedID- 22402140 | This study aimed to evaluate vegf concentration in the bronchoalveolar lavage fluid (balf) of scleroderma patients with interstitial lung disease, to correlate the cytokine levels in plasma and in the lung with pulmonary functional, radiological and cellular parameters, and with the progression of lung disease. |
| PubMedID- 25110305 | Good outcome of interstitial lung disease in patients with scleroderma associated to anti-pm/scl antibody. |
| PubMedID- 22723597 | Up-regulated expression of hla-drb5 transcripts and high frequency of the hla-drb5*01:05 allele in scleroderma patients with interstitial lung disease. |
| PubMedID- 21552414 | Background: scleroderma (ssc) patients with active interstitial lung disease (ild) experience a decline in lung function and increased mortality; cyclophosphamide (cyc) therapy may stabilize lung function at one and two years follow-up. |
| PubMedID- 22826062 | interstitial lung disease often coexists with scleroderma and is accompanied by functional lung abnormalities. |
| PubMedID- 20352228 | To evaluate the role and the prognostic value of bronchoalveolar lavage (bal) in scleroderma patients with interstitial lung disease. |
Page: 1